Trazium

This article is about an antidepressant. For the antibiotic with the trade name Trazium, see ceftriaxone.

Trazium
INN: Trazium esilate

Clinical data
Routes of administration	Oral
ATC code	none
Legal status
Legal status	In general: uncontrolled
Identifiers
IUPAC name 1-(4-Chlorophenyl)-1-hydroxy-1,4-dihydro[1,2,4]triazino[6,1-a]isoquinolin-5-ium
CAS Number	97110-59-3
PubChem CID	72166
ChemSpider	65139
UNII	1PO9LWW5IN
CompTox Dashboard (EPA)	DTXSID70910384
Chemical and physical data
Formula	C17H13ClN3O
Molar mass	310.76 g·mol^−1

Trazium (EGYT-3,615) is an antidepressant drug which was never marketed.^[1] It has psychostimulant-like effects and its actions appear to be mediated by the dopaminergic and adrenergic systems.^[2] It was formulated as a salt with ethanesulfonic acid and given the generic name trazium esilate (INN).^[3]

References

1. David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
2. Gyertyán I, Petöcz L, Bajnógel J, et al. (July 1989). "Possible involvement of the dopaminergic system in the mode of action of the potential antidepressant trazium esilate". Arzneimittel-Forschung. 39 (7): 775–81. PMID 2551306.
3. "Trazium Esilate". ChemSpider.^{[permanent dead link‍]}